Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Meningococcal Conjugate Vaccine in Adolescents and Children

View through CrossRef
Disease caused by Neisseria meningitidis is associated with high mortality rates and significant sequelae. Quadrivalent (A, C, Y, W-135) polysaccharide meningococcal vaccine has been available for more than 20 years, and although used widely for adolescents entering college, it has a number of limitations, including short duration of immunity and lack of a herd effect. A quadrivalent meningococcal conjugate vaccine has recently been licensed and endorsed for use in adolescents 11 to 12 years of age, at age 15, or at college entry. Among the key features of the new meningococcal conjugate vaccine are stimulation of both B-cell-dependent and T-cell-dependent immune responses, induction of immunologic memory and booster effects, long-term protection, reduction of nasopharyngeal carriage of N. meningitidis, and herd immunity. Large randomized, double-blind studies in adolescents and 2- to 10-year olds have demonstrated the immunogenicity as well as the safety and tolerability of the new meningococcal conjugate vaccine formulation.
Title: Meningococcal Conjugate Vaccine in Adolescents and Children
Description:
Disease caused by Neisseria meningitidis is associated with high mortality rates and significant sequelae.
Quadrivalent (A, C, Y, W-135) polysaccharide meningococcal vaccine has been available for more than 20 years, and although used widely for adolescents entering college, it has a number of limitations, including short duration of immunity and lack of a herd effect.
A quadrivalent meningococcal conjugate vaccine has recently been licensed and endorsed for use in adolescents 11 to 12 years of age, at age 15, or at college entry.
Among the key features of the new meningococcal conjugate vaccine are stimulation of both B-cell-dependent and T-cell-dependent immune responses, induction of immunologic memory and booster effects, long-term protection, reduction of nasopharyngeal carriage of N.
meningitidis, and herd immunity.
Large randomized, double-blind studies in adolescents and 2- to 10-year olds have demonstrated the immunogenicity as well as the safety and tolerability of the new meningococcal conjugate vaccine formulation.

Related Results

Meningococcal Disease and Carriage in the Philippines: A Review of Recent Data
Meningococcal Disease and Carriage in the Philippines: A Review of Recent Data
This article reviews recent data on meningococcal disease and carriage in the Philippines. It aims to provide information on the epidemiology of meningococcal disease, its carriage...
Increased Attack Rate of Meningococcal Disease in Children With a Pregnant Mother
Increased Attack Rate of Meningococcal Disease in Children With a Pregnant Mother
Objective. To investigate the relationship between meningococcal disease and family composition, especially pregnancy in mothers. Methods. This was a retrospective m...
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Background: The pandemic is at a paradoxical stage, with vaccine roll out initiated but a significantly elevated level of infection and death. Hope for recovery lies in high equita...
Social-Cyber Maneuvers During the COVID-19 Vaccine Initial Rollout: Content Analysis of Tweets (Preprint)
Social-Cyber Maneuvers During the COVID-19 Vaccine Initial Rollout: Content Analysis of Tweets (Preprint)
BACKGROUND During the time surrounding the approval and initial distribution of Pfizer-BioNTech’s COVID-19 vaccine, large numbers of social media users took...
Identification of a meningococcal adhesin that inhibits epithelial cell migration
Identification of a meningococcal adhesin that inhibits epithelial cell migration
<p>Neisseria meningitidis virulence is polygenic, therefore comparing many genomes may not yield strictly disease-associated virulence factors. An alternative approach is com...

Back to Top